Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Micardis® in Patients With Essential Hypertension

NCT02187705 ·Status: COMPLETED

Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

NCT02242838 ·Status: COMPLETED

Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

NCT02245464 ·Status: COMPLETED

An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

NCT00982735 ·Status: COMPLETED

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

NCT02242396 ·Status: COMPLETED

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

NCT02262611 ·Status: COMPLETED

Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

NCT02262637 ·Status: COMPLETED

Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension

NCT02242370 ·Status: COMPLETED ·Phase: PHASE4

Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

NCT00659607 ·Status: COMPLETED

PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg

NCT00936208 ·Status: COMPLETED

A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension

NCT00635232 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

NCT00257491 ·Status: COMPLETED ·Phase: PHASE3

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

NCT00879411 ·Status: COMPLETED

A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients

NCT06174766 ·Status: RECRUITING ·Phase: PHASE3

Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan

NCT01108796 ·Status: COMPLETED

Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

NCT00946829 ·Status: COMPLETED

A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)

NCT01104545 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

NCT02177422 ·Status: COMPLETED ·Phase: PHASE3

Essential Hypertension

NCT01264692 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

NCT00904371 ·Status: COMPLETED

Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters

NCT00615108 ·Status: COMPLETED

An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

NCT00904215 ·Status: COMPLETED

A Study to Investigate the Antihypertensive Efficacy of MK0954

NCT00887250 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)

NCT00543413 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension

NCT00522925 ·Status: COMPLETED ·Phase: PHASE2